Ann: Monepantel Trial Achieves Successful Anti-Cancer Outcome, page-332

Looking forward to the near future, must be lots happening in the background. Not liking the SP however the company seems to be in a very good position with positive results in the bag.

Still see much value In PAA and MPL applications to walk away any time soon.

1. Covid-19
2. Elanco
3. Phase II human
4. MPL human trial paper for publication in a peer review journal
5. Tablet formulation aiming to increase uptake of monepantel into the blood and reduce tablet number for future human trials
6. Epichem "has now identified a Business Development Partner in the US market and is proactively searching for further Business Development Partners in the US and Europe to represent our product and service offerings moving forward. There are a number of encouraging projects in the
pipeline awaiting tender decisions."

It has been an interesting week, congrats to those who exited and made a profit

I have currently tempered my expectations and would be glad to see the SP end the week @ 10.3c + haha

Any how enjoy your weekend all